Special Policy Interpretation on Abnormal Patent Applications: Regulatory System, Eight Typical Behaviors, and Practical Responses

Industry Insight · Policy Interpretation

Special Policy Interpretation on Abnormal Patent Applications

This article is compiled from the special training session “Special Policy Interpretation on Abnormal Patent Applications” and is provided for reference by innovators, patent agencies, and industry peers. The policy interpretation shall be subject to the latest official texts published by the authorities.


Key Points at a Glance

  • Regulatory system: CNIPA coordination + local office collaborative handling + industry association early warning + public supervision.
  • Eight typical behaviors: Identical content/simple combination, fabrication/plagiarism/cobbling, AI random generation, feature piling, mismatch with business, malicious division, false inventor change, other disruptive acts.
  • Legal framework: Article 20 of the Patent Law (good faith), Article 11 of the Implementing Regulations, Revision Decision No. 8484 of January 2026, and Order No. 77, the Provisions on Regulating Patent Application Behaviors.
  • Five-step handling: Clue discovery → internal verification → local handling → party defense → final disposition.
  • Accompanying penalties: No fee reduction, public exposure, dishonesty list, deduction from quantity statistics, recovery of subsidies, referral to judicial authorities.

1

Policy Background

In recent years, the patent field has seen rampant problems such as batch “watered-down” patents, patent reselling, and fake R&D, with the prominent issue of “large but not strong, patent bubbles.” The state has made a top-level decision: IP work is undergoing two major shifts—from a major importer to a major creator, and from pursuing quantity to improving quality. The special campaign against abnormal patent applications aims precisely to purify the industry environment and promote the high-quality development of the patent cause.

2

Multi-level Regulatory System

The supervision of abnormal applications has formed a multi-level system of “CNIPA coordination + local office collaborative handling + industry association early warning + public supervision”:

CNIPA

Established a task force for full-process clue collection and internal verification

Local IP Offices

Receive notifications, urge cessation, guide voluntary withdrawal

Industry Associations

Send early-warning emails first to agencies on the precision-service list

Public

Can provide clues through reporting channels

3

Eight Typical Behaviors of Abnormal Patent Applications

01Identical Content or Simple Combination
Repeatedly filing identical solutions; dividing conventional modules for batch submission
02Fabricated / Plagiarized / Cobbled-together Data
Fabricating experimental parameters; plagiarizing published domestic and foreign patents
03AI Randomly Generated Solutions
Relying on programs or AI to automatically generate drawings or solutions
04Piling up Features to Narrow Protection
Adding many unnecessary features to evade inventiveness examination
05Application Mismatched with Business
A huge gap between the company’s business scope and the patent’s technical field
06Malicious Division to Evade Supervision
Batch filing by multiple entities and addresses to avoid verification
07False Change of Inventor
Shell companies batch-file then resell, or fraudulently obtain subsidies
08Other Order-disrupting Behaviors
Maliciously delaying examination, falsely advertising “guaranteed grant,” etc.
Key correction of misconception: There is no necessary connection between the number of features, the size of the protection scope, and inventiveness. Inventiveness assessment focuses on the height of innovation and technical contribution—not “the more features, the easier to be granted.”

4

Remediation Results and Legal Framework

Top-level direction: Two major shifts in IP work—from a major importer to a major creator, from pursuing quantity to improving quality.

Policy timeline:

2021
CNIPA established the source-control working group for patent application quality and conducted research in more than ten provinces and cities
2023
Revision of the Patent Law Implementing Regulations; Article 11 explicitly prohibits “falsification and deception”
December 2025
CNIPA, together with the Ministry of Public Security and the State Administration for Market Regulation, issued a document designating 2026 as the “Year of Regulating and Standardizing the Agency Industry”

Legal basis and supporting measures:

  • Article 20 of the Patent Law—principle of good faith (legislative purpose: encouraging innovation and promoting scientific and technological progress);
  • Implementing Regulations—Articles 11 / 50 / 59 / 69 / 88 / 100: strict prohibition of falsification, full-process examination, maximum fine of RMB 100,000;
  • Guidelines for Patent Examination—including Revision Decision No. 8484 of January 2026 (strengthening inventor verification, prohibiting agencies from filing on their own, and improving the principle of res judicata);
  • Order No. 77, Provisions on Regulating Patent Application Behaviors—identification of 8 typical behaviors, handling measures, and legal liabilities;
  • Supporting penalties—credit management + “Blue Sky” action + special campaigns (dishonesty list, no fee reduction, recovery of subsidies, referral to judicial authorities).

5

Governance Effect Data (with Typical Cases)

800k+
2021 notifications
97.9%
2021 withdrawal rate
94%
2022 withdrawal rate

Typical cases:

Collusion by public officials

A local IP official colluded with an unemployed person to fabricate more than 200 patents and defraud over RMB 900,000 in rewards, and was sentenced to 7 years in prison with a fine

Repeat-offending agency

After being interviewed and warned, the agency again filed identical abnormal applications on behalf of clients, and was ordered to rectify and given a warning

University team fraud

A professor’s team at a top-985 university directly translated and filed foreign published patents, crossing the bottom line of research integrity

6

Full Investigation and Handling Process (Five Steps)

1

Clue Discovery

Full-process examination or public report
2

Internal Verification

Task force reviews and notifies local offices
3

Local Handling

Urge cessation, guide withdrawal
4

Party Defense

Submit opinions + R&D evidence
5

Final Disposition

Restore or reject/withdraw

New development—association email early-warning mechanism: Agencies on the precision-service list receive an early-warning email from the association first, and a formal specialized office action letter may be issued later.

On “all applications rejected by examiners after appeal”: If the task force cannot confirm but also cannot clear the suspicion, the case enters an “intermediate state” → proceeds to substantive examination under suspicion → intensified examination → rejected under Article 11 of the Regulations or examined under ordinary provisions.

Defense evidence checklist: Industry-university-research cooperation agreements, R&D records, experimental data, product production / sales documents, personnel qualification certificates, etc.

7

Practical Hot Topics

(1) Same-day Dual Filing (One Case, Dual Filing)

  • The dual-filing declaration must be checked at the application stage; it cannot be supplemented if omitted;
  • When the invention is granted, the utility model must be in a valid state;
  • The waiver declaration is announced simultaneously with the dual-filing status;
  • An invention without the declaration checked will be rejected;
  • The patent office’s internal rules are not yet fully unified; for OAs involving divisional applications being granted, the advice is: respond on the due date and wait for the situation to become clear.

(2) Choice of Examination Channel

  • Regular: Utility models / designs are processed in submission order; inventions are queued by the effective date of substantive examination;
  • Prioritized examination: Covers inventions, utility models, designs, reexamination, and invalidation;
  • Fast examination / pre-examination: Provided by local protection centers as a public-interest pre-service;
  • Deferred examination: Handled upon the applicant’s request;
  • Overall principle: expedite when fast is needed, delay when slow is appropriate, with dynamic allocation of examination resources.

8

Supporting Penalty Measures

The following circumstances will be penalized:
  • × No fee reduction
  • × Public exposure
  • × Credit penalty / dishonesty list
  • × Deduction from patent quantity statistics
  • × Recovery of fiscal rewards / subsidies
  • × Referral to judicial authorities if a crime is suspected
  • × Rejection or deemed withdrawal (termination of examination)

“Marching from a major IP country to an IP powerhouse, quality is the foundation and good faith is the bottom line.” The entire industry must abandon the old mindset of “emphasizing quantity over quality” and work together to purify the industry environment.

Q

Frequently Asked Questions about Abnormal Applications

Q1What is an “abnormal patent application”?

Patent applications that violate the principle of good faith and are not made for the purpose of genuine innovation. The training materials categorize them into eight typical behaviors (identical content/simple combination, fabrication/plagiarism/cobbling, AI random generation, feature piling, mismatch with business, malicious division, false inventor change, other order-disrupting behaviors). The basis for determination is Article 20 of the Patent Law (good faith), relevant provisions of the Implementing Regulations, and Order No. 77, the Provisions on Regulating Patent Application Behaviors.

Q2What are the consequences of being identified as an abnormal application?

The accompanying penalties include: no fee reduction, public exposure, inclusion in credit penalties / dishonesty list, deduction from patent quantity statistics, recovery of fiscal rewards or subsidies, referral to judicial authorities if a crime is suspected, as well as rejection or deemed withdrawal (termination of examination). These are compounded by ongoing supervision such as the “Blue Sky” action and special campaigns, affecting the credit records of both applicants and agencies.

Q3How to defend after receiving an abnormal-application office action or warning?

The handling process includes a “party defense” stage: submit a statement of opinions + R&D evidence within the prescribed time limit. Valid defense evidence includes industry-university-research cooperation agreements, R&D records, experimental data, product production / sales documents, personnel qualification certificates, etc. Be sure to observe the response deadline, as overdue submission is deemed a waiver of defense. Valid evidence can restore normal examination; if the appeal is unsuccessful, the examination authority will continue to issue a specialized office action letter and take further action as appropriate.

Q4How can applicants and agencies avoid “stepping on landmines”?

The core is to hold the bottom line of “genuine innovation”: do not fabricate; do not plagiarize or cobble together; do not rely on AI to randomly generate solutions; do not maliciously divide to evade supervision; do not falsely change inventors. The technical field of the application should match your own business scope, and you should retain complete R&D process evidence. At the same time, abandon the misconception that “more features make granting easier,” and win with technical contribution rather than feature quantity.

Q5Can AI-generated solutions be patented?

The training explicitly lists “relying on programs or AI to automatically generate drawings or solutions” as one of the typical abnormal-application behaviors. But this does not mean AI cannot be used in patent work—the key is whether humans have made a substantial creative contribution. If AI is only an aid and the core innovation is still completed by R&D personnel with genuine technical contribution, a normal application may be filed; if the solution is randomly generated by a program and lacks genuine R&D, it falls within the scope of remediation.

Q6What should be noted about same-day dual filing (one case, dual filing)?

① The dual-filing declaration must be checked at the application stage and cannot be supplemented if omitted; ② the utility model must be in a valid state when the invention is granted; ③ the waiver declaration is announced together with the dual-filing status; ④ an invention without the declaration checked will be rejected. It is advised to strictly verify the declaration checkbox to avoid procedural errors that lead to loss of rights.

Q7How can I find out whether my patent application has been included in abnormal-application monitoring?

Clues may come from the full-process examination (acceptance, preliminary examination, substantive examination, reexamination, international applications, etc.) or from public reports. A recent development is the association email early-warning mechanism—agencies on the precision-service list receive an early-warning email from the association first. It is recommended that applicants maintain smooth communication with their agency and the local IP office, and routinely retain R&D evidence so as to defend themselves promptly and effectively when inquiries are received.

Zhihaiyida Related Services

We provide services such as patent annual fee monitoring, trademark portfolio planning, and IP compliance consulting to help you avoid abnormal-application risks and safeguard your patent assets:


Disclaimer: This article is a policy summary and industry observation and does not constitute legal advice. For specific case handling, please refer to the official documents and examination decisions issued by the China National Intellectual Property Administration and relevant authorities, and consult a professional patent agent when necessary.

Share: WeiboQQ
Scroll to Top